|Bid||26.02 x 2900|
|Ask||34.97 x 1100|
|Day's Range||26.14 - 26.24|
|52 Week Range||20.46 - 26.56|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||6.57%|
|Beta (5Y Monthly)||N/A|
|Expense Ratio (net)||0.79%|
Pharmaceutical exchange-traded funds (ETFs) offer investors access to a basket of U.S.-based and foreign stocks of drug manufacturers and related companies in a single investment. Stocks included in these funds are Pfizer, Inc.
The cancer immunotherapy ETF is soaring today as some of its holdings presented very promising results at the ASCO conference. Find out more on the podcast.
Policy easing in the Chinese economy, cooling trade tensions with the United States and Beijing's efforts for more urbanization have boosted these sector ETFs in 2019.